Evoq Remedies intimates BSE of its board meeting scheduled for May 14, 2026, under SEBI LODR Reg. 29(1).
The board will consider and approve audited financial results for H2 and FY ending March 31, 2026.
The meeting will be held at the company's registered office in Ahmedabad at 4:00 PM.
Other matters may be discussed with the permission of the meeting's chairperson.